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Abstract
Background: Uganda introduced a multipronged intervention, the supervision, performance assessment, and recognition
strategy (SPARS), to improve medicines management (MM) in public and not-for-profit health facilities. This paper, the first
in a series, describes the SPARS intervention and reports on the MM situation in Uganda before SPARS (baseline).
Methods: To build MM capacity at health facilities, health workers were trained as MM supervisors to visit health facilities,
assess MM performance, and use the findings to provide support and standardize MM practices. Performance is assessed
based on 25 MM indicators covering five domains: dispensing quality (7 indicators), prescribing quality (5), stock
management (4), storage management (5) and ordering and reporting (4). From the end of 2010 to 2013, MM supervisors
assessed baseline MM performance of 1384 government (85 %) and private not-for-profit facilities at all levels of care in
about half of Uganda’s districts.
Results: The overall MM baseline median score was 10.3 out of a maximum of 25 with inter-quartile range (IQR) of 8.7–11.
7. Facility domain scores (out of a maximum of 5) were as follows: storage management, median score of 2.9 (IQR 2.3–3.4);
stock management 2.3 (IQR 2.0–2.8), ordering and reporting 2.2 (IQR 1.3–2.5), and dispensing quality 2.1 (IQR 1.7–2.7).
Performance in prescribing quality was 0.9 (IQR 0.4–1.4). Significant regional differences were found: overall scores were
highest in the Northern region (10.7; IQR 9.2–12.4) and lowest in the Eastern region (9.6; (IQR 7.8–11.2) (p< 0.001). Overall
scores did not differ by facility ownership; however, government facilities scored lower in dispensing and storage and
higher in ordering and reporting. Hospitals scored higher overall and in domains other than prescribing and stock
management. Districts classified a priori as having high capacity for implementing SPARS had higher scores at baseline
compared to lower-capacity districts.
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Conclusion: Assessing and building national capacity in MM is needed in both private not-for-profit and government
facilities at all levels of care. The indicator-based, multipronged SPARS assessment has been described here, while the
strategy’s impact has yet to be documented.
Keywords: Medicines management, Supervision, Performance assessment, Pharmacy indicators, Medicines management
indicators, Public sector, Uganda
Background
For a health care system to improve individual and
population health, needed medicines must be available,
accessible, affordable, and appropriately used [1]. To
ensure these requirements, numerous pharmaceutical
sector processes, including ordering products, managing
stock and storage, and prescribing and dispensing medi-
cines must be effective and efficient. These processes are
complex and depend on many factors, such as the avail-
ability and wise use of money, human resources, and
information, and management capacity [2, 3].
Despite Uganda’s long-standing commitment to ensur-
ing universal access to essential medicines, the health
system and the pharmaceutical supply chain continue to
face many well-documented constraints [4]. For ex-
ample, in 2009/2010, the availability of a basket of 22
vital items in public health facilities averaged 53 %, and
the Ministry of Health reported that less than 10 % of all
facilities had six vital indicator tracer medicines available
[5, 6]. In 2013, only 35 % of public health care providers
correctly diagnosed at least four of five common condi-
tions,[7] and providers at only 1 % of health facilities
provided the correct treatment for simple cough and
cold [5]. Meanwhile, less than 8 % of 376 pharmacy
posts in the public sector were filled, and 79 % of all
facilities lacked shelves, making it impossible to manage
medicines appropriately [5, 8, 9].
In general, access to medicines has been addressed
through fragmented and vertical interventions without
considering the broader health system [2]. In Uganda, a
number of predominantly educational interventions have
been implemented to strengthen the health care system
and build capacity at district and facility levels [10–12].
However, these interventions have not produced signifi-
cant or sustainable improvements in medicines manage-
ment (MM) or access [5]. Combinations of educational,
managerial, regulatory, and financial interventions and
multimethod training approaches can improve health
system practices [12–14]. Several studies have demon-
strated that supervision and on-the-job training signifi-
cantly increase health workers’ morale and performance
in providing services and managing medicines [15, 16]).
Supervision that is supportive is more effective than
supervision that is punitive [17–19], and a strategy that
combined rewards with performance assessment
increased vaccine coverage and strengthened vaccine
management at facility level [20, 21].
As a multidisciplinary group comprising members of
government and non-governmental organizations that is
implementing a strategy to improve the medicines situ-
ation in Uganda, we define MM as all the processes that
support the implementation of the national medicines
policy in ensuring that good quality essential medicines
and health supplies (EMHS) are available and appropri-
ately prescribed and dispensed at health facilities.
Uganda’s Ministry of Health adopted the national super-
vision, performance assessment, and recognition interven-
tion strategy (SPARS) to improve MM in government and
private not-for-profit health (PNFP) facilities that com-
bines several intervention approaches. Although similar
elements have been recommended to improve perform-
ance of health workers [14, 22], a strategy that combines
these five interventions to improve MM has not previ-
ously been described or implemented nationally.
Uganda’s health system
Uganda had a population of 36.6 million people in 2014,
with an average annual growth rate of 3.2 % per year;
the estimated population will be about 44 million people
in 2020 [23]. Communicable diseases such as HIV, mal-
aria, lower respiratory infections, meningitis, and tuber-
culosis cause most years of life lost [24].
Both public and private for-profit providers deliver the
country’s health care services. PNFP providers are con-
sidered part of the public sector. Under a decentralized
health care delivery model, the Ministry of Health sets
health policy and provides strategic direction, while local
governments are responsible for service delivery. The
National Drug Authority is the government arm respon-
sible for assuring the quality of all medical products in
the country through regulations of manufacturers, whole-
salers, pharmacies, and drug shops.
In 2013, Uganda’s 112 districts had 5229 health facil-
ities, of which 55 % were government-owned, 17 % were
PNFP, and 28 % private for-profit [23, 24]. Uganda’s pub-
lic sector consisted of two government national referral
hospitals, 14 regional referral hospitals, 144 general
hospitals, 197 health centers (HC) level 4, 1289 HC3 and
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2941 HC2 facilities, and more than 25,000 village health
teams regarded as HC1 [25]. The government-owned
National Medical Stores (NMS) supplies EMHS to all
government health facilities. NMS uses a combination of
a “pull” ordering system for hospitals and HC4 facilities
and a “push” system, whereby central-level decision
makers determine the types and quantities of medicines
that HC3 and HC2 facilities will receive in a kit, with
amounts depending on facility level. The Joint Medical
Stores is a private not-for-profit medical supplier owned
by the medical bureaus (Catholic, Protestant, Muslim,
and Orthodox), which provides medicines for its PNFP
facility customers using a pull-based distribution system
for facilities at all levels of care. Both warehouses distrib-
ute EMHS directly to health care facilities.
Per capita expenditure on EMHS in 2013/14 was
US$2.40, of which US$0.99 was for basic EMHS (up
from US$0.50 in 2010/11), and the remaining US$1.41
was spent mainly on HIV, tuberculosis, and malaria
commodities. Funding of EMHS is heavily dependent on
donor funds, which covered 77 % of EMHS costs in
2013/14 [8].
The objectives of this paper, the first in a series of
papers on SPARS, are to a) describe the components of
SPARS, an innovative multipronged intervention strategy
to improve MM in Uganda, and b) report on the MM
situation in Uganda before the introduction of SPARS
(other than its assessment tool). This paper thus de-
scribes the baseline MM situation in Uganda prior to
SPARS implementation. Additional papers will describe
the SPARS intervention feasibility and impacts on MM
at health facilities over time.
Method
This section describes SPARS and its components
followed by detailing the district and facility selection
and collection of baseline facility performance data using
the SPARS tool.
Supervision, performance assessment, and recognition
strategy
SPARS is based on the theory that combining different
interventions increases the likelihood of positive change.
The strategy, which was nationalized in 2012, includes
educational, managerial, regulatory, and financial inter-
ventions combined with performance assessment. MM
supervisors (MMS) provide on-the-job supervision and
mentoring of health workers. They also give managerial
support to staff in the form of manuals and tools needed
to standardize MM practices. Performance assessment
focuses on 25 MM indicators measured at baseline and
at each following supervisory visit to guide support and
ensure evidence-based decision making. On the regula-
tory side, SPARS helps facilities pass the National Drug
Authority’s inspections to license health facility pharma-
cies. Recognition in the form of reward items for health
facilities, district health officers, and the MMS are part
of SPARS.
Supervision
MMS who implement SPARS are district-level health
care staff members who are employed by the govern-
ment. District health officers select MMS based on their
leadership and management skills and interest in and
knowledge of pharmaceutical issues. Each district has
one district MMS and two to five sub-district MMS who
could be clinical officers, nurses, midwives, pharmacy
staff, or storekeepers. In addition to their other duties,
the district MMS oversee the sub-district MMS and also
supervise the district hospital and HC4 facilities, while
sub-district MMS supervise public sector HC2 and HC3
facilities. District health officers monitor performance of
MMS with oversight from regional pharmacists and the
Ministry of Health’s Pharmacy Division.
MMS receive 2 weeks of training and pass an exam at
Makerere University in managing medicines, problem-
solving, communication, and how to mentor health care
workers and assess performance using the indicator-
based tool. MMS who passed the exam receive 1 week
of practical training in the field. The MMS are provided
a netbook to enter the findings from the performance
assessment and they receive 3 days of training in the use
of the netbook and the electronic performance assess-
ment tool. To increase their computer skills, we provide
flash drives with self-paced learning aids about various
software packages and other technologies.1 To facilitate
MMS’ travel to their facilities, which are often in rural
areas with rutted dirt roads, they receive motorbikes,
riding gear, training, and examination in defensive rid-
ing. Once MMS pass their defensive riding exam, they
are ready to provide regularly scheduled on-the-job
training and supportive supervision visits at their
assigned facilities.
District MMS and health sub-district MMS are ex-
pected to complete three and five supervisory visits per
month, respectively. To standardize the time between
visits, a facility should receive a visit every other month.
After five visits, the interim time can be increased to
every 4 months to maintain acceptable performance.
In addition, managerial tools to facilitate the supervi-
sion are provided to the MMS and to the supervised fa-
cilities. An EMHS management manual that describes
procedures for receiving and storing medicines and sup-
plies, completing order discrepancy reports, filling out
stock cards, completing the stock book, conducting
stock counts, and dispensing medicines is distributed to
all health facilities and MMS. Other tools include stock
cards, stock books, dispensing logs, and standard
Trap et al. Journal of Pharmaceutical Policy and Practice  (2016) 9:21 Page 3 of 15
operating procedures. MMS also receive laminated job
aids to guide their explanations of how to correctly dis-
pense medicines and use the dispensing guidelines. A
supervisory book is placed at the facility and filled out by
the MMS at each visit, recording findings and agreed next
steps. A white board in the pharmacy displays a spider
graph with results from the performance assessment and
progress between visits in the five MM domains. To mo-
tivate, coordinate, and strengthen SPARS implementation,
MMS and district health officers attend biannual regional
meetings and district meetings where they discuss national
and district SPARS performance reports.
In 2013, the National Drug Authority introduced regu-
lar inspections of government and PNFP facility pharma-
cies to assess their adherence to good pharmacy
practices. SPARS has been shown to help facilities pre-
pare for these inspections, and there is 73 % overlap of
the indicators used in the good pharmacy practices in-
spection tool and the SPARS performance assessment
tool [26].
Performance assessment
Using evaluation as a management tool is well known
[27]. MMS use record reviews, observation of staff
practices, and patient exit interviews to assess and
evaluate performance based on 25 MM indicators.
The MMS note assessment results in the supervisory
book and in the spider graph (Fig. 1). While in the
field, they manually fill out a data collection form
(Additional file 1) or (starting early 2012) use an
identical electronic form on a netbook and submit it
when they are able to access the Internet. Because
many of the MMS were not computer literate at the
start of the program, we designed and piloted an
electronic form in the same format as the paper form
and provided targeted computer training.
The SPARS performance assessment uses practical
performance indicators to flag areas for improvement in
a real-life setting, guide and focus the supervision and
provide the health staff with an understanding of their
facility’s issues and achievements. The 25 indicators are
classified into five MM domains 1) dispensing quality, 2)
prescribing quality, 3) stock management, 4) storage
management, and 5) ordering and reporting.
The indicators chosen for the SPARS tool were based
on tools used globally to assess pharmaceutical sectors,
MM problems identified previously in surveys of the
pharmaceutical sector in Uganda, and on an understand-
ing of the processes needed in a system for ensuring that
EMHS are available, of good quality, and used appropri-
ately, in line with Uganda’s essential medicines policy.
The rational drug use and the dispensing or patient care
indicators are similar to validated World Health
Organization (WHO) drug use core indicators [28]. In
addition, complementary WHO indicators to measure
adherence to standard treatment guidelines and the
stock and storage management indicators have been
validated and used globally [16, 28, 29]. To get an indi-
cation of how well staff is adhering to standard treat-
ment guidelines in the time available for the assessment
visit, and as a majority of facilities have only a few
prescribers, we reduced the number of records required
for review to 10 instead of the 30 to 100 recommended
by World Health Organization [28].
Fig. 1 Spider graph of facility performance scores. Each facility has a spider graph printed on a white board that can be displayed in the
pharmacy. The graph depicts performance progress between visits in the five MM assessment domains and functions as a management tool. This
spider graph depicts facility scores for visits 1 to 6
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To facilitate using the assessment as a management
tool, each of the five domains has a maximum score of
5; therefore, the overall SPARS score has maximum
score of 25. However, the number of indicators per do-
main varies from four to seven, so the contribution of an
individual indicator to a domain score of 5 varies; for
example, if the domain has five indicators, each is worth
one point; if the domain has seven indicators, each is
worth 5/7th of a point. If an indicator is not assessed for
a facility, that indicator score is not included in the
domain score calculation (rather than given a score of
“0”). For example, if a facility did not have a score for
one of the seven dispensing quality indicators (marked
“not applicable”), then each of the six remaining indica-
tors is worth 5/6th of a point instead of 5/7th of a point.
MMS create a spider graph with a facility’s domain
scores (Fig. 1) as a visual representation of a facility’s
performance at each visit, which is useful for supportive
supervision and performance tracking of the facility.
Additional file 1 in the supplementary file includes the
data collection tool that was used in both manual and
electronic versions. The tool describes each indicator
and its scoring. Additional file 2 in the supplementary
file describes the indicators by domains. Scores for indi-
cators are composites of scores of sub-indicators and ag-
gregated to scores that range from 0 to 1. Indicator,
domain, and overall scores are primarily for comparing
scores within facilities across visits.
To manage the country SPARS data, we developed a
centralized data hub, called the pharmaceutical informa-
tion portal, for storing, analyzing, disseminating, and
reporting SPARS data. The hub aggregates the data that
MMS submit, so that users can generate and share na-
tional and district reports.
Each of the 1384 facilities in the sample has an overall
SPARS score and five domain scores. However, because
not all facilities assessed every indicator at baseline, the
number of facilities contributing to each indicator score
varies from 33 to 1384.
Recognition scheme
The SPARS recognition component is a way to motivate
the district health officers, MMS, and health facility
workers and acknowledge progress in managing medi-
cines. The rewards and linkage to performance was
decided in discussion with health system officials at the
start of SPARS based on identified needs and what was
doable within rules and regulations. Most rewards are only
given once; some are given annually (i.e., mobile telephone
airtime and payment for each submitted SPARS perform-
ance assessment report). Rewards are largely linked to per-
formance; for example, MMS who pass the training
course receive a bag with pens, a calculator, and a net-
book; when they pass the driving license and defensive
riding tests, they receive the riding gear, motorbike, and
motorbike license; after a specified number of supervisory
visits, MMS are recognized with telephone time, etc.
Other recognition items for MMS and district health offi-
cers include Internet airtime and payment for expenses
linked to the SPARS visits they make. Over time, we sim-
plified the expense payments per visit; now MMS receive
UGX 30,000 (US$12) when they submit a SPARS visit re-
port to cover fuel, food, and minor motorbike repair. We
also provide funds annually for major motorbike repairs,
servicing, and new tires.
Similarly, facilities that achieve a certain score—for
example, 3 out of 5 in dispensing quality—receive a
measuring cylinder, plastic dispensing bottles, and stain-
less steel tumblers for drinking water. When expiry re-
cords are available and updated and expired medicines
are stored separately, the facilities are acknowledged
with five mugs and 10 pens. Other things that help them
deliver quality pharmacy services include tablet counting
trays, copies of the Uganda Clinical Guidelines, soap,
wall clocks to help track dispensing time, wall thermom-
eters, masking tape to mark shelves, permanent markers,
cleaning supplies, rat traps, pens, rulers, and ring
binders. We also provide items for personal use such as
T-shirts, calendars, toilet paper, sugar, tea, and mugs.
The implementation of the SPARS was made possible
through donor support by the United States Agency for
International Development (USAID).
Selection of districts and facilities
In 2009, we approached district health officers from
the then 80 districts in Uganda regarding their inter-
est in implementing SPARS. The overall response rate
was 81 % (n = 65/80) and lowest in the Northern
region with 76 %, followed by Central (81 %),
Western and Eastern (84 %) regions. We ranked re-
sponsive districts according to their commitment to
improving the availability of EMHS and scored their
estimated capacity to carry out SPARS based on six
evaluation criteria: district profile (size, population,
number of facilities, Internet connectivity); infrastruc-
ture (district store size and condition); EMHS (avail-
ability and district distribution issues and solutions);
partners (number and type of other development
partners in the district); management and finance (per
capita EMHS budget and expenditures); and staff
(number of pharmaceutical staff members). Based on
their scores, we classified their estimated capacity into
“high,” “medium,” and “low” strata.
We then randomly selected 44 districts from the three
strata (high, medium, and low) using systematic
sampling of 20, 12, and 12 districts, respectively, and
checked that all four regions were fairly equally repre-
sented; one more Western district was later selected
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randomly from all districts to reach a total of 45 dis-
tricts, resulting in 15, 13, 9, and 8 districts from the
Western, Eastern, Northern, and Central regions,
respectively.
Government and PNFP facilities within districts
were selected for inclusion by the MMS. The district-
MMS selected the higher-level facilities (hospitals and
HC4), and the sub-district MMS selected HC3 and
HC2 for SPARS visits. The guiding principle was for
an MMS to select five facilities to visit during the
first month and another five during the following
month. In the third month, the MMS would revisit
the initial five facilities, and in the fourth month,
revisit the second five facilities, and so on. In
principle and with time, all facilities are SPARS
supported, but the time it takes before all facilities
receive a first visit depends on both the number of
visits the MMS can make every month and the
number of facilities under his or her responsibility,
which ranges from four to more than 20. The intent
was that during the first year, each MMS would cover
at least 10 facilities, and visit the rest in the following
year(s).
We also randomly selected another nine districts from
the remaining 21 districts that had responded to the
expression of interest. Sampling included two districts
from three regions and three districts from the Central
region. The selected districts represented high, medium,
and low strata (1, 4, and 4, respectively). The nine dis-
tricts would not be exposed to SPARS, so they could
later serve as comparison facilities for assessing the
impact of the SPARS intervention. In each of the nine
districts, we included the district hospital and randomly
selected one HC4 (when possible), three HC3, and two
HC2 facilities for a total of 63 government and PNFP
facilities, although ultimately, we only included 61 facil-
ities due to incomplete data collection. In total, 15 % of
intervention and 9 % of control facilities were PNFP. As
a national strategy, SPARS will eventually be rolled out
to include all districts in Uganda.
Statistical analysis
We calculated measures of central tendency (medians,
means) together with inter-quartile ranges (IQR) for
the five domains and for the 25 indicator scores
across categories of background characteristics. We
used nonparametric equality of medians testing using
Pearson’s chi-square test to determine whether median
scores differed significantly across categories, because the
domain scores were not normally distributed (based on
results of the Shapiro-Wilk test). We present means and
medians to illustrate skewness of the data. We used
STATA software version 13 to perform all statistical
analyses.
Ethical considerations
This study describes a national capacity-building strategy
and reports medicines management data collected by
MMS under the Ministry of Health. The study did not
involve human subjects or use personal data. As it con-
stituted a Ministry of Health-initiated system interven-
tion, no ethical review was required.
Results
Facilities with baseline assessments
From the last months of 2010 to 2013, 1499 health
facilities had an initial SPARS visit to determine base-
line MM scores. Because only 17 facilities received
visits in 2010, we combined 2010 and 2011 data.
Only 1384 (92 %) facilities were included in the base-
line analyses due to lost reports or incomplete scores.
A score was not applicable if, for example, the facility
did not yet have the stock book; it was marked miss-
ing values if the store room was locked making the
data inaccessible. Only three facilities had baseline
values for all 25 indicators, and 83 % had values for
at least 21 indicators. More than 5 % of the facilities
had no values for seven indicators. The completeness
of indicator recording improved somewhat over the
course of baseline assessments and with the addition
of electronic data collection.
We report baseline scores in overall medicines
management and each of the five domains from
1384 facilities. More than half of the supervised fa-
cilities were government owned (85 %) and HC2
level (58 %). Table 1 shows that across the four re-
gions proportions of facilities were comparable with
regard to ownership and level of care but were not
comparable with respect to year of baseline assess-
ment and district capacity rank.
Overall and five domain scores of MM
Generally, medicines management in Ugandan facil-
ities was weak. The median overall performance
score at baseline was 10.3 out of 25 (41 %). How-
ever, a few facilities scored close to 20 and one facil-
ity had a score close to 25, which is the maximum
score possible. Scores for the five domains are given
in Fig. 2 and Table 2. Facilities had high median
scores (of 5) in the domain of storage management
(median 2.9, IQR 2.3–3.4) and stock management
(2.3, 2.0–2.8). Scoring in prescribing quality was
poor (0.9, 0.4–1.4).
As shown in Table 2, the median overall scores were
around 10/25 and varied significantly by region (p <
0.001). Similar medians of overall scores were found in
government-owned and PNFP facilities (10.2 vs. 10.6,
NS). Median overall scores depended on level of care
(HC3 facilities: 10.1; HC2: 10.2; HC4: 11.0; and hospitals
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11.6 [p < 0.001]). Over the 4-year period during which
the baseline visits occurred, the median overall
SPARS scores differed (10.1 in 2010/11; 10.4 in 2012;
11.0 in 2013 [p = 0.002]). Median SPARS scores of fa-
cilities in districts based on pre-study capacity also
differed (10.4 among those with high capacity, 9.6
among those with medium capacity, and 10.4 among
those with low capacity), corresponding to MM prac-
tices across facilities in districts with a different cap-
acity levels (p = 0.009).
Table 1 Characteristics of health facilities at the baseline assessment, by region
Western Eastern Central Northern Total Chi-
square
p-value
No % No % No % No % No %
Total 550 100 383 100 273 100 178 100 1384 100
Ownership
GOVT 472 85.8 319 83.3 226 82.8 158 88.8 1175 84.9 0.244
PNFP 78 14.2 64 16.7 47 17.2 20 11.2 209 15.1
Level of care
HC2 319 58.0 227 59.3 155 56.8 103 57.9 804 58.1 0.159
HC3 171 31.1 118 30.8 93 34.1 61 34.3 443 32.0
HC4 47 8.5 19 5.0 18 6.6 7 3.9 91 6.6
Hospital 13 2.4 19 5.0 7 2.6 7 3.9 46 3.3
Year
2011 214 38.9 300 78.3 244 89.4 65 36.5 823 59.5 <0.001
2012 235 42.7 80 20.9 26 9.5 105 59.0 446 32.2
2013 101 18.4 3 0.8 3 1.1 8 4.5 115 8.3
District Rank
Good 353 64.4 196 54.4 144 53.1 133 75.1 826 60.9 <0.001
Average 26 4.7 116 32.2 71 26.2 0 0.0 213 15.7
Poor 169 30.8 48 13.3 56 20.7 44 24.9 317 23.4
GOVT government, PNFP private not for profit, HC health center; year indicates the year of the baseline assessment visit, district rank indicates the level of capacity
of a district to implement the SPARS interventions







Fig. 2 Box and whisker diagram of baseline domain performance scores of 1384 public health facilities in Uganda, 2010–2013. The figure displays
the distribution of scores in the five domains. Shown are the minimum scores excluding outliers (first whisker - 25th percentile -1.5*interquartile
range [IQR]) and maximum score excluding outliers (last whisker –75th percentile +1.5*IQR); the first quartile (lower part of the box), the median
(line in box), and the third quartile (upper part of the box) and dots show the outlying scores. The spaces between the different parts of the box
indicate the degree of dispersion (spread) and direction of skewness in the data for each of the five domains (on a scale of 0–5)
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Table 2 Baseline performance scores, overall and in 5 medicines management domains, by public sector facility characteristics, Uganda, 2010–2013
Characteristics Facilities
%






















































































































































































































Table 2 Baseline performance scores, overall and in 5 medicines management domains, by public sector facility characteristics, Uganda, 2010–2013 (Continued)


































The maximum overall score is 25; the maximum score on each domain is 5
IQR interquartile ranges, PNFP Private not-for-profit facilities, Govt Government facilities
amedians and means are presented to allow for easy assessment of distributions; analyses are only conducted on medians














Seven indicators (each with a possible maximum score
of 1), are used to assess dispensing quality (Table 3). Dis-
pensing time of less than 30 s is scored 0, between 31
and 60 s is scored 0.5, and 61 s or above scored at the
maximum score of 1 (Additional file 1). The median
score was 0.0 (IQR 0.0–0.5), indicating that dispensing
time was too short to ensure good practices. About
three-quarters of the facilities had a score of 0.5 that
measured the availability of appropriate packaging mate-
rials, such as dispensing envelopes and containers, but
only a quarter scored 0.5 for availability of dispensing
equipment, such as a counting tray, spatula or spoon,
and measuring cylinder. About a quarter of the facilities
scored 0.8 or more on availability of dispensing services
including, chairs, privacy, hand-washing, and drinking
water. About three-quarters of the facilities had a score
of 0.5 on patient care, which is a measure of any dis-
crepancy between prescribed and dispensed medicines
and the patient’s knowledge of how much medicine to
take, how often, how long, and the reasons for taking
the medicine. Labeling assesses whether medicines were
labeled with the medicine’s name, strength, quantity,
date, dose, patient name, and facility name, for which a
quarter of the facilities had a score of 0.3. Rationing of
antibiotics occurred if the patient received less than a
full course of amoxicillin or co-trimoxazole. Rationing
occurs when a facility is running out of stock or if a pa-
tient cannot pay for a full course, and the indicator’s me-
dian score was 1 as rationing rarely occurs. Median
dispensing scores differed significantly by regions, facility
types, and levels of care. Dispensing quality median
scores did not differ across years of baseline assessments
or estimated levels of district capacity (Table 2).
Prescribing quality
Prescribing quality measured by five indicators (each
with a maximum score of 1), was poor overall, with me-
dian indicator scores ranging from 0.0 to 0.4 of 5
(Table 3). Most facilities did not correctly implement the
legally mandated prescription recording system that re-
quires recording of dates, outpatient department or in-
patient number, diagnosis, medicines prescribed, name
of prescriber, and quantity prescribed and dispensed
(half of the facilities scoring 0.0). The rational prescrib-
ing indicator is comprised of five sub-indicators, each
with a maximum score of 0.2 and the maximum score
for the indicator of 1. The five sub-indicators are average
number of medicines prescribed per encounter (median
score 0.0 of 0.2); percentage of medicines prescribed by
generic name (median score 0.0 of 0.2); percentage of
encounters with one or more antibiotics (score 0.0 of
0.2); percentage of encounters with one or more injec-
tions (score 0.1 of 0.2); and percentage of encounters
with the diagnosis recorded (score 0.2 of 0.2) for an
overall median score of 0.4 of 1.0. Adherence to standard
treatment guidelines was poor for all three common
conditions, with about three-quarters of the facilities
scoring 0.0 on these indicators. Lowest adherence scores
were found for cough and cold and diarrhea, which were
often treated with antibiotics. Malaria guidelines require
testing followed by treatment if needed with artemether
and lumefantrine combination (first-line) or quinine (se-
vere), but no antibiotics, and adherence was poor.
Overall median prescribing quality scores differed sig-
nificantly across regions, years of baseline assessment,
and estimated levels of district capacity (Table 2). Me-
dian prescribing quality scores did not differ by facility
types or levels of care.
Stock management
Stock management is measured based on four indicators
(each with a maximum score of 1) using a tracer list of
15 EMHS. Baseline results showed that about 25 % of
the facilities had a score of 1.0, implying that stock cards
were available for all tracer items, but not filled in cor-
rectly (median score = 0.0) (Table 3). When available and
filled in, the median score on stock recording was 0.6 on
indicator 15, which assesses whether the quantity of
stock recorded on the stock card is in agreement with
the quantity counted on the shelf. The stock book had
only been introduced at the beginning of 2013. About a
quarter of the facilities had a score of 0.1 out of 1 on in-
dicator 16, which assesses correct filling in of the stock
book. Median stock management scores differed signifi-
cantly across regions but not across facility types, levels
of care, baseline assessment years, or estimated levels of
district capacity.
Storage management
In the area of storage management, measured using five
indicators (each with a maximum score of 1), median
scores ranged between 0.3 and 1.0 (Table 3). Facilities
had the highest possible median score (1.0) in cleanliness
in the pharmacy (dispensary and main store); the me-
dian score of appropriate hygiene of the pharmacy (with
sub-indicators assessing availability of clean and func-
tioning toilets with toilet paper and hand-washing facil-
ities with soap) was 0.4. Three-quarters of the facilities
scored 0.3 or higher in appropriate system of storage of
medicines and supplies, where supplies are stored sys-
tematically on labeled shelves or in cupboards with stock
cards. The median score for meeting standards for stor-
age conditions measured with 12 sub-indicators includ-
ing those assessing pest infestation, protection from
sunlight, temperature regulation and monitoring, condi-
tion of the roof, adequate storage space, lockable storage,
fire safety equipment, and cold storage was 0.7. Half of
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the facilities had a score of 0.3 or higher on the final in-
dicator 21, storage practices of medicines in pharmacy,
which comprises sub-indicators that assess whether
boxes are on the floor, older medicines are shelved to be
dispensed first, there is a separate space for and record
of expired medicines, opened tins in the dispensary have
the lids on, and bottles are dated when opened. Median
storage management scores differed significantly across
regions, facility types, levels of care, and estimated levels
of capacity, but not years of baseline assessment
(Table 2).
Ordering and reporting
Ordering and reporting quality was measured using four
indicators (each with a maximum score of 1) (Table 3).
On the reorder level calculation indicator, which in-
cludes knowledge of the vital, essential, and necessary
product classification, the median score was 0.0, while
75 % of the facilities had a score of 1.0 on the indicator
assessing timeliness of orders and distribution which
measures higher level facilities’ ordering against official
schedules and the overall lead time from ordering to re-
ceipt of goods. Half of the facilities scored 1.0 or less on
their accuracy of the health management information
system report, which compares reported stock-out days
to stock card information for a sample of six items. On
the composite indicator of legally required filing systems,
which includes sub-indicators measuring the use of dis-
crepancy reports, delivery notes, previous order records,
and prescription and dispensing logs, the median score
was 0.5. Table 2 shows that median ordering and report-
ing scores did not differ across the regions and levels of
care. Scores did differ significantly across facility types,
years of baseline assessment, and estimated levels of dis-
trict capacity.
Discussion
Our study describes SPARS as an innovative, multi-
pronged strategy to improve MM in Uganda and reports
on the baseline facility performance in MM as measured
by the indicator-based, multidomain SPARS assessment
tool. With a median overall score of 10.3 out of 25, we
show that assessing and building national capacity in
Table 3 Baseline performance scores on 25 medicines
management indicators of public sector facilities in Uganda,






1. Dispensing time 1356 0.0 (0.0-0.5);
0.3
2. Packaging material 1383 0.5 (0.5-0.5);
0.5
3. Dispensing equipment 1381 0.0 (0.0-0.5);
0.3
4. Services available at dispensing domain 1384 0.5 (0.5-0.8);
0.6
5. Patient care 1341 0.5 (0.5-0.8);
0.6
6. Labeling 1344 0.0 (0.0-0.3);
0.1
7. Rationing of antibiotics 803 1.0 (1.0-1.0);
1.0
Prescribing quality




9. Rational prescribing 1380 0.4 (0.2-0.4);
0.4




11. Adherence to standard treatment
guidelines for cough and cold
1272 0.0 (0.0-0.0);
0.1





13. Availability of stock card/ledger book 1384 0.9 (0.8-1.0);
0.8
14. Correct filling of stock card 1360 0.0 (0.0-0.0);
0.0




16. Stock book correctly filled 33 0.0 (0.0-0.1);
0.2
Storage management
17. Cleanliness of the pharmacy 1380 1.0 (0.5-1.0);
0.7
18. Hygiene of the pharmacy 1384 0.4 (0.4-0.6);
0.5




20. Storage conditions 1380 0.7 (0.6-0.8);
0.7
21. Storage practices of medicines in
pharmacy (stores and dispensary)
1384 0.3 (0.2-0.5);
0.4
Ordering and reporting quality
22. Reorder level calculation 1250 0.0 (0.0-0.0);
0.0
Table 3 Baseline performance scores on 25 medicines
management indicators of public sector facilities in Uganda,
2010–2013. Maximum and best score for each indicator is 1
(Continued)
23. Timeliness of order and distribution 63 1.0 (1.0-1.0);
0.8




25. Filing 1329 0.5 (0.5-0.5);
0.5
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MM are much needed in both PNFP and government fa-
cilities at all levels of care. The poor overall performance
of Ugandan facilities is confirmed by results from the
National Drug Authority’s good pharmacy practices in-
spection program, with equally low passing rates of 58 %
and 57 % in PNFP and government facilities, respectively
[26]. On the positive side, we note that a few facilities
achieved perfect domain and total scores on the SPARS
assessment tool, prior to the SPARS intervention.
Specific MM performance in Uganda
We assessed MM performance in five domains covering
appropriate medicines use (prescribing and dispensing
quality) and the practices needed to ensure availability
and maintain quality of EMHS. Assessment indicators
have face validity, have been used globally [28–30], and
were easily adapted to Uganda’s context. The MMS were
trained in the purpose and use of the tool and indicators.
They found the assessment tool understandable and
were largely able collect data in one visit.
The assessment did not include pharmaceutical finan-
cial management indicators because HC2 and HC3 facil-
ities receive medicines in kits free of charge. Financial
management skills of staff at higher level facilities were
assessed separately with different indicators (data not
reported).
Dispensing quality
We noticed differences in dispensing quality by facility
ownership. Several sub-indicators of dispensing quality
are related to infrastructure and equipment, such as the
availability of counting trays, drinking water, and chairs
for waiting, which may explain higher dispensing quality
scores of PNFP facilities that are better equipped than
government facilities.
The labeling indicator had the lowest score in the dis-
pensing domain. The indicator assesses whether the
medicine is labeled with the critical information such as
the name of the patient and the medicine. Several factors
may explain this finding: Dispensing envelopes are
sometimes out of stock, patient numbers may be too
high for staff to find time to label envelopes, or staff
may be using dispensing envelopes with pre-printed pic-
tograms (without a need to fill all of the information).
The latter instance resulted in a poor labeling score, but
a better patient care score because a pictogram printed
on the dispensing envelope effectively informs the pa-
tient when to take the medicine and how much to take.
Using the same indicators, a study in Botswana found
similar patient care quality, but scored much better on
labeling quality, which was found to be related to the
training and qualifications of the dispenser. Dispensing
time in Botswana was also found to be higher—well over
100 s—and dependent on the level of care and other
facility differences [31]. It was encouraging to see that in
almost all cases, full courses of prescribed medicines
were dispensed. That is, little rationing took place, com-
pared to international data that highlight rationing as a
problem behavior, especially when patients pay for their
medicines, such as in the PNFP sector [28].
Prescribing quality
Prescribing performance scores were low for all levels of
care. Patient demand and health workers’ inability to
diagnose correctly result in symptom treatment and
polypharmacy [7]. Polypharmacy, low use of generic
names, and overuse of antibiotics have been found glo-
bally, and little progress has been made over time [13,
32–34]. Because prescribing habits are multifactorial,
they are more difficult to change than filling out a stock
card, for example. As a result, improving prescribing will
require a combination of interventions [12, 33].
Adherence to standard treatment guidelines and over-
use of antimicrobials are also well-known global prob-
lems, and Uganda is no exception [5, 32, 34, 35]. We did
not find differences in prescribing quality based on facil-
ity ownership, while other studies have found higher use
of antibiotics and lower adherence to standard treatment
guidelines in the private for-profit and not-for-profit sec-
tors [33].
Stock management
Correctly completed stock cards are fundamental to
quantifying the medicines needed and ensuring availabil-
ity. Similar to findings in Zimbabwe, where only about
half of available stock cards and 13 % of stock books
were filled out correctly [16], our study indicates that
stock cards were available in facilities, but not filled out
correctly. In the few facilities that had the newly intro-
duced stock book, staff found it difficult to complete it
correctly. Both studies confirm that keeping stock re-
cords correctly is difficult, especially when a new tool is
introduced.
Stock management differed by level of care. HC4 facil-
ities and hospitals order their EMHS every 2 months
and benefit from having a well-implemented stock man-
agement system, which is not the case for HC2 and HC3
facilities that receive a bimonthly kit, making stock
tracking less relevant to their day-to-day tasks. We hope
through the SPARS strategy to build sufficient capacity
at HC 2 and HC3 in quantification and stock manage-
ment to eventually facilitate a shift from the present kit
system to an order-based pull system, to optimize use of
limited resources.
Storage management
Most storage management indicators assess facilities’
construction or equipment and scores vary by facility
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ownership and level of care. PNFP facilities are con-
structed and equipped by donors and often have more
space, shelves, refrigerators, running water, and electri-
city than government facilities [9]. Similarly, higher level
facilities are more likely to have rooms dedicated for
storage and shelving.
Ordering and reporting
Although only higher level facilities place bimonthly
orders and HC2 and HC3 receive a pre-packed kit, all
health facilities are expected to submit monthly stock
status reports to the national health management infor-
mation system (HMIS), which the Ministry of Health
has emphasized strongly, particularly in the government
sector. As would be expected, performance was highest
on the accuracy of data for six tracer medicines entered
into the HMIS, and HC4 facilities and hospitals scored
highest on the ability to calculate reorder levels, which is
a routine task for them. Government facilities also
scored higher than PNFP facilities, which may be ex-
plained by NMS’s 2010 introduction of strict order and
delivery schedules for government facilities. During the
time of the study, PNFP facilities prepared orders as
needed and were not restricted to an order and delivery
schedule by the Joint Medical Store (their supplier); in
addition, PNFP facilities infrequently submitted reports
to the HMIS in a timely fashion. We will be implement-
ing order and delivery schedules, with door-to-door
delivery and the establishment of an order budget line at
Joint Medical Store for all PNFP facilities.
Performance variations
We found significant regional variations in the overall
SPARS scores and in the scores for each domain except
the ordering and reporting domains. Generally, facilities
in the Northern region scored high except for stock
management; whereas, those in the Eastern region had
the weakest performance. Although, as mentioned
below, scores across regions need to be compared with
caution, we believe that civil unrest in the Northern
region had previously deprived the populations there of
most health service interventions; now facilities in the
area are keen to catch up and make full use of the
opportunities offered. The reasons for the weak per-
formance in the Eastern region are unclear.
Scores differed by level of care. Hospitals outper-
formed lower level facilities both overall and in all
SPARS domain areas apart from prescribing quality.
Aside from being better equipped, having better
structures and storage facilities for storing medicines
and supplies, hospitals and other higher level facilities
have dedicated staff to manage stock and storage,
while fewer staff members at lower levels of care per-
form all MM tasks.
Baseline assessments started at the end of 2010 and
peaked in 2011. Because districts and facilities were
added, some baseline visits happened in 2013. Overall,
MM performance at baseline differed across the years,
likely due to performance differences in two domains,
ordering and reporting and prescribing. From 2010 on-
ward, the NMS continuously improved the order and
delivery schedule by distributing EMHS directly to facil-
ities. In addition, NMS reintroduced the kit supply sys-
tem for HC2 and HC3 facilities. In 2011, NMS focused
on increasing awareness of and adherence to the new
order modes and cycles, which by 2013 had become a
well-established routine. The 2012 revision of the na-
tional standard treatment guidelines, which were made
available and implemented at all government and PNFP
health facilities, may have contributed to improving
baseline prescribing domain scores from 2010/11 to
2013. We found no correlation between scores at the
baseline visit and experience of the MMS.
The SPARS intervention
Several studies have documented the need for a complex
systematic approach to improving medicines manage-
ment [2, 3, 36, 37]. When developing SPARS, we chose a
multidimensional performance assessment to allow iden-
tification of diverse issues that influence MM and then
to intervene with multipronged approaches to change
MM behaviors and practices effectively and sustainably
[14]. SPARS interventions have been implemented in
Ugandan facilities since the baseline assessment. Their
effects on different aspects of MM over time will be re-
ported in a separate paper.
Potential study limitations
The study has the following potential limitations. Al-
though the study facilities represent one-third of the
government and PNFP facilities of Uganda, government
facilities were slightly overrepresented (85 % of the sam-
ple) compared to the actual proportion of 70 % [23].
However, the PNFP sample was sufficient to detect dif-
ferences of at least 10 % in baseline performance by fa-
cility ownership with 70 % power. The facilities were not
randomly selected but MMS chose the facilities to be
visited initially and MMS purposefully might have given
priority to government facilities, well-performing facil-
ities, or nearby facilities; any potential bias introduced
by purposeful sampling by the MMS is expected to be
limited because over 80 % of the facilities in the selected
districts have been included in the baseline assessment.
In addition, the sample’s regional representation corre-
sponds to the SPARS rollout that started in the Western
region, followed by Eastern and Central regions, and
ended with the Northern region. The sample represents
the distribution of facilities by level of care, with the
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highest proportion of facilities being HC2 followed by
HC3, with fewer higher-level facilities.
Another limitation is that the baseline data are not
compared to findings derived from a validated compre-
hensive performance assessment tool. The performance
assessment tool is primarily a management not a re-
search tool. As such, its purpose is to highlight MM do-
mains within a facility over time so that the responsible
MMS and the facility staff can focus activities for im-
provement. For this reason, priority was given to consist-
ent expression and intuitive graphical representation of
domain scores, rather than consistent weighting of items
contributing to scores. Because domain scores are gener-
ated from different numbers of indicators, individual in-
dicators contribute differently to the overall domain
scores. In addition, some indicators could not be
assessed at all facilities. In these cases, rather than penal-
izing facilities with a “0” score, we calculated domain
scores on non-missing indicators, effectively weighing
indicators differently in facilities where all indicators
were assessed and those that were missing indicator
scores. The majority of facilities had at least one indica-
tor without a value. The stock book correctly filled indi-
cator had the most missing values because stock books
were introduced late in the baseline assessment period;
therefore, only 36 facilities could be assessed on that in-
dicator. We have not yet evaluated reproducibility or
inter-rater reliability of the tool and the indicators.
In addition, baseline data was collected over a period
of 4 years. We found that the facilities assessed in 2013
had a higher baseline score compared to those assessed
in 2010/11. Changes in MMS experience, facility behav-
ior, and system context over time could explain the dif-
ference. During the baseline data collection, some MMS
left, new MMS joined, and overall MMS experience may
have increased. Increased attention by the MMS in the
district could have changed facility behavior and im-
proved baseline scores over time (Hawthorne effect).
Lastly, new medicines order processes and cycles could
have effected change.
Despite these caveats, we believe that the results of
our analysis of data collected with the SPARS manage-
ment tool illustrate the shortcomings of MM in Uganda.
The SPARS assessment tool will likely be revised over
time as some indicators may become obsolete, changes
may be needed to strengthen new aspects of medicines
management, or when there is a need to clarify indica-
tors. Revisions will take place after impact of the SPARS
strategy over time has been evaluated.
Conclusions
Medicines management was poor in this sample of more
than 1000 public sector health care facilities in Uganda.
Our baseline results highlight the need to build national
capacity for monitoring and improving medicines man-
agement in both government and PNFP facilities at all
levels of care. The baseline assessment of MM perform-
ance with the indicator-based multidimensional SPARS
assessment tool has been implemented successfully as a
first step of a long-term national process to continually
measure and improve MM. Since the baseline assess-
ment, all aspects of SPARS have been implemented.
However, the effects of SPARS still have to be evaluated.
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